cyanates has been researched along with benzoxazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, E; Mutschler, E; Quinke, K; Spahn, H | 1 |
| Bowen, WD; Comeau, A; McCurdy, CR; Mesangeau, C; Nicholson, H | 1 |
| Bowen, WD; Liu, CZ; McCurdy, CR; McVeigh, BM; Mottinelli, M; Nicholson, HE; Wong, NK | 1 |
3 other study(ies) available for cyanates and benzoxazoles
| Article | Year |
|---|---|
(-)-(S)-flunoxaprofen and (-)-(S)-naproxen isocyanate: two new fluorescent chiral derivatizing agents for an enantiospecific determination of primary and secondary amines.
Topics: Amines; Benzoxazoles; Chemical Phenomena; Chemistry; Chemistry, Physical; Chromatography, High Pressure Liquid; Fluorescent Dyes; Humans; Indicators and Reagents; Isocyanates; Mass Spectrometry; Naproxen; Optical Rotation; Spectrometry, Fluorescence; Stereoisomerism | 1989 |
Characterization of CM572, a Selective Irreversible Partial Agonist of the Sigma-2 Receptor with Antitumor Activity.
Topics: Analgesics, Opioid; Animals; Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Isocyanates; MCF-7 Cells; Protein Binding; Rats; Receptors, sigma | 2015 |
Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Topics: Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Isocyanates; Membrane Proteins; Neoplasms; Receptors, sigma | 2021 |